Serial SARS-CoV-2 antibody titers in vaccinated dialysis patients: prevalence of unrecognized infection and duration of seroresponse.

Caroline M HsuDaniel E WeinerHarold J ManleyDana MiskulinVladimir LadikJill FramentChristos ArgyropoulosKenneth AbreoAndrew ChinReginald GladishLoay SalmanDoug JohnsonEduardo K Lacson

Published in: medRxiv : the preprint server for health sciences (2023)

Among maintenance dialysis patients, 20-24% of SARS-CoV-2 infections were undiagnosed. Given this population's vulnerability to COVID-19, ongoing infection control measures are needed. A three-dose primary mRNA vaccine series optimizes seroresponse rate and durability.

Keyphrases

sars cov
end stage renal disease
chronic kidney disease
peritoneal dialysis
ejection fraction
newly diagnosed
coronavirus disease
climate change
patient reported outcomes
patient reported